We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,860 results
  1. Determination of the median lethal dose of zinc gluconate in mice and safety evaluation

    Background

    Zinc Gluconate (ZG) is a safe and effective supplement for zinc. However, there is limited research on the optimal dosage for intravenous...

    Yong-cai Wang, **a Yang, ... Qing-wen Shan in BMC Pharmacology and Toxicology
    Article Open access 05 February 2024
  2. Lethal pulmonary thromboembolism in mice induced by intravenous human umbilical cord mesenchymal stem cell-derived large extracellular vesicles in a dose- and tissue factor-dependent manner

    Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have obvious advantages over MSC therapy. But the strong procoagulant properties of...

    Bian-lei Yang, Yao-ying Long, ... Qiu-bai Li in Acta Pharmacologica Sinica
    Article 24 June 2024
  3. Lethal and sublethal impacts of membrane-fed ivermectin are concentration dependent in Anopheles coluzzii

    Background

    Ivermectin is a well-tolerated anthelminthic drug with wide clinical and veterinary applications. It also has lethal and sublethal effects...

    Monique A. M. Shepherd-Gorringe, Marie W. Pettit, Frances M. Hawkes in Parasites & Vectors
    Article Open access 16 May 2024
  4. AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from lethal Pseudomonas aeruginosa pneumonia

    Pseudomonas aeruginosa poses a significant threat to immunocompromised individuals and those with cystic fibrosis. Treatment relies on antibiotics,...

    Jordyn A. Lopes, Nicole E. Garnier, ... Sarah K. Wootton in Gene Therapy
    Article 27 April 2024
  5. YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge

    Ebola virus (EBOV) and related filoviruses such as Sudan virus (SUDV) threaten global public health. Effective filovirus vaccines are available only...

    Viktor Lemmens, Lara Kelchtermans, ... Kai Dallmeier in npj Vaccines
    Article Open access 11 July 2023
  6. Alteration in Cerebral Metabolism in a Rodent Model of Acute Sub-lethal Cyanide Poisoning

    Introduction

    Cyanide exposure can occur in various settings such as industry and metallurgy. The primary mechanism of injury is cellular hypoxia from...

    Oladunni Alomaja, Frances S. Shofer, ... David H. Jang in Journal of Medical Toxicology
    Article 09 February 2023
  7. Sub-lethal exposure to chlorfenapyr reduces the probability of develo** Plasmodium falciparum parasites in surviving Anopheles mosquitoes

    Background

    Pyrethroid resistance in the key malaria vectors threatens the success of pyrethroid-treated nets. To overcome pyrethroid resistance,...

    Prisca A. Kweyamba, Lorenz M. Hofer, ... Mgeni M. Tambwe in Parasites & Vectors
    Article Open access 03 October 2023
  8. Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy

    Background

    Previously suggested modifiable risk factors for prostate cancer could have resulted from detection bias because diagnosis requires a...

    **aoshuang Feng, Yiwen Zhang, ... Konrad H. Stopsack in British Journal of Cancer
    Article 28 October 2023
  9. ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys

    Nipah virus (NiV) is a highly pathogenic and re-emerging virus, which causes sporadic but severe infections in humans. Currently, no vaccines against...

    Neeltje van Doremalen, Victoria A. Avanzato, ... Vincent J. Munster in npj Vaccines
    Article Open access 21 December 2022
  10. A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection

    A new vectored vaccine MVA-VLP-SUDV was generated against Sudan ebolavirus (SUDV) combining the advantages of the immunogenicity of a live attenuated...

    Delphine C. Malherbe, Arban Domi, ... Alexander Bukreyev in npj Vaccines
    Article Open access 25 July 2022
  11. Principles of EC50, ED50, pD2 and pA2 Values of Drugs

    The effects of most drugs depend on the dose that is provided to the subject. In line with this, we have a concept called “dose descriptors”, which...
    Chapter 2022
  12. Maximum Tolerated Dose (MTD) Studies in Drug Toxicology Assessments

    In order to transition a new chemical entity (NCE) from the discovery arena into nonclinical development and potentially the clinic, a comprehensive...
    Yevgeniya E. Koshman, Brett R. Winters, ... Michael K. Pugsley in Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
    Living reference work entry 2023
  13. Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge

    SARS-CoV-2 is a viral respiratory pathogen responsible for the current global pandemic and the disease that causes COVID-19. All current WHO approved...

    Ting Y. Wong, Katherine S. Lee, ... F. Heath Damron in npj Vaccines
    Article Open access 14 March 2022
  14. Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development

    Objective

    Lack of ideal mathematical models to qualify and quantify both pathogenicity, and virulence is a dreadful setback in development of new...

    Saganuwan Alhaji Saganuwan in BMC Research Notes
    Article Open access 15 June 2020
  15. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

    Background

    According to current evidence, the best treatment for fit patients with non-resectable pancreatic cancer (PC) is combination chemotherapy,...

    Louise Skau Rasmussen, Stine B. Winther, ... Morten Ladekarl in BMC Cancer
    Article Open access 16 June 2023
  16. Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost

    Background

    Local recurrence is the most common pattern of failure in head and neck cancer. It can therefore be hypothesised that some of these...

    Anna Embring, Eva Onjukka, ... Signe Friesland in Radiation Oncology
    Article Open access 07 April 2023
  17. Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers

    Background

    Somatic copy number alterations are a hallmark of cancer that offer unique opportunities for therapeutic exploitation. Here, we focused on...

    Stephan Krieg, Thomas Rohde, ... Darjus F. Tschaharganeh in Genome Medicine
    Article Open access 17 June 2024
Did you find what you were looking for? Share feedback.